Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S8ZJ
|
||||
| Former ID |
DNC014171
|
||||
| Drug Name |
3alpha-(1'-Methyl-2'-Indolecarbonyloxy)-tropane
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530355] | ||
| Formula |
C18H22N2O2
|
||||
| Canonical SMILES |
CN1C2CCC1CC(C2)OC(=O)C3=CC4=CC=CC=C4N3C
|
||||
| InChI |
1S/C18H22N2O2/c1-19-13-7-8-14(19)11-15(10-13)22-18(21)17-9-12-5-3-4-6-16(12)20(17)2/h3-6,9,13-15H,7-8,10-11H2,1-2H3/t13-,14-/m1/s1
|
||||
| InChIKey |
WGAYVVNWRFPKMG-ZIAGYGMSSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine receptor 3A | Target Info | Inhibitor | [530355] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | 5HT3 type receptor mediated signaling pathway | ||||
| Reactome | Ligand-gated ion channel transport | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Iron uptake and transport | |||||
| References | |||||